Management characterizes 2025 as a transition from structural rightsizing to a growth-oriented 'offense' strategy, achieving profitability levels not seen since 2021. Performance was driven by internal execution and cost initiatives rather than market recovery, as the broader mattress industry remained down low single digits. The 'Path to Premium Sleep' strategy gained traction, with the Rejuvenate 2.0 collection representing over 50% of showroom mattress revenue at an average selling price of $5,800. ...